ALNYLAM PHARMACEUTICALS INC (ALNY) Stock Earnings Estimates
NASDAQ:ALNY • US02043Q1076
332.92 USD
+1.68 (+0.51%)
At close: Feb 27, 2026
332.92 USD
0 (0%)
After Hours: 2/27/2026, 5:33:09 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.828B 76.24% | 2.248B 22.97% | 3.714B 65.19% | 5.634B 51.70% | 7.315B 29.84% | 8.61B 17.70% | 9.793B 13.74% | 11.099B 13.34% | 12.048B 8.55% | 12.868B 6.81% | 13.684B 6.34% | |
| EBITDA YoY % growth | -228.121M 69.20% | -120.215M 47.30% | 557.236M 563.53% | 1.309B 134.91% | 2.193B 67.53% | 6.144B 180.16% | 3.118B -49.25% | 3.842B 23.22% | 3.49B -9.16% | 3.927B 12.52% | N/A | |
| EBIT YoY % growth | -282.175M 64.06% | -176.885M 37.31% | 501.578M 383.56% | 1.212B 141.64% | 2.055B 69.55% | 3.16B 53.77% | 3.029B -4.15% | 3.794B 25.26% | 5.415B 42.73% | 6.887B 27.18% | 7.589B 10.19% | |
| Operating Margin | -15.43% | -7.87% | 13.51% | 21.51% | 28.09% | 36.70% | 30.93% | 34.18% | 44.95% | 53.52% | 55.46% | |
| EPS YoY % growth | -3.56 58.89% | -2.17 39.04% | 1.98 191.24% | 6.70 238.33% | 13.00 94.00% | 21.81 67.83% | 24.97 14.50% | 28.37 13.61% | 35.27 24.31% | 40.17 13.89% | 44.97 11.96% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.10 349.90% | 1.74 440.73% | 2.00 -5.30% | 2.11 157.24% | 1.95 77.18% | 2.25 29.72% | 2.59 29.65% | 3.01 42.65% |
| Revenue Q2Q % growth | 1.182B 98.93% | 1.354B 75.01% | 1.454B 16.41% | 1.548B 41.11% | 1.484B 25.55% | 1.574B 16.25% | 1.673B 15.06% | 1.788B 15.50% |
| EBITDA Q2Q % growth | 232.93M 617.10% | 351.06M 2,789.38% | 457.21M 11.48% | 835.99M 346.16% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 206.49M 1,042.28% | 315.72M 2,049.01% | 360.16M -2.13% | 347.68M 163.96% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 0.82 226.15% | 1.15 | -0.33 | -28.48% |
| Q3 2025 Q2Q % growth | 2.11 342.53% | 0.76 | 1.35 | 177.15% |
| Q2 2025 Q2Q % growth | -0.51 -292.31% | -0.73 | 0.22 | 30.60% |
| Q1 2025 Q2Q % growth | -0.44 15.38% | -1.03 | 0.59 | 57.21% |
| Q4 2024 Q2Q % growth | -0.65 40.91% | -0.64 | -0.01 | -2.21% |
| Q3 2024 Q2Q % growth | -0.87 -175.65% | -0.91 | 0.04 | 4.00% |
| Q2 2024 Q2Q % growth | -0.13 94.12% | -1.10 | 0.97 | 88.19% |
| Q1 2024 Q2Q % growth | -0.52 62.86% | -1.21 | 0.69 | 56.90% |
| Q4 2023 Q2Q % growth | -1.10 34.52% | -1.35 | 0.25 | 18.47% |
| Q3 2023 Q2Q % growth | 1.15 142.75% | -1.36 | 2.51 | 184.40% |
| Q2 2023 Q2Q % growth | -2.21 3.49% | -1.40 | -0.81 | -58.30% |
| Q1 2023 Q2Q % growth | -1.40 30.00% | -1.80 | 0.40 | 22.24% |
| Q4 2022 Q2Q % growth | -1.68 22.22% | -1.91 | 0.23 | 12.09% |
| Q3 2022 Q2Q % growth | -2.69 -64.02% | -1.78 | -0.91 | -51.47% |
| Q2 2022 Q2Q % growth | -2.29 -42.24% | -1.66 | -0.63 | -37.75% |
| Q1 2022 Q2Q % growth | -2.00 -16.96% | -1.88 | -0.12 | -6.57% |
| Q4 2021 Q2Q % growth | -2.16 -3.35% | -1.57 | -0.59 | -37.46% |
| Q3 2021 Q2Q % growth | -1.64 24.77% | -1.60 | -0.04 | -2.56% |
| Q2 2021 Q2Q % growth | -1.61 -3.21% | -1.65 | 0.04 | 2.16% |
| Q1 2021 Q2Q % growth | -1.71 6.56% | -1.76 | 0.05 | 3.03% |
| Q4 2020 Q2Q % growth | -2.09 | -1.74 | -0.35 | -19.89% |
| Q3 2020 Q2Q % growth | -2.18 | -1.67 | -0.51 | -30.49% |
| Q2 2020 Q2Q % growth | -1.56 | -1.75 | 0.19 | 10.74% |
| Q1 2020 Q2Q % growth | -1.83 | -1.92 | 0.09 | 4.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 1.097B 84.95% | 1.196B | -98.967M | -8.27% |
| Q3 2025 Q2Q % growth | 1.249B 149.35% | 997.35M | 251.676M | 25.23% |
| Q2 2025 Q2Q % growth | 773.689M 17.26% | 669.92M | 103.769M | 15.49% |
| Q1 2025 Q2Q % growth | 594.189M 20.20% | 597.54M | -3.351M | -0.56% |
| Q4 2024 Q2Q % growth | 593.166M 34.90% | 595.47M | -2.304M | -0.39% |
| Q3 2024 Q2Q % growth | 500.919M -33.26% | 543.76M | -42.841M | -7.88% |
| Q2 2024 Q2Q % growth | 659.825M 107.00% | 452.99M | 206.835M | 45.66% |
| Q1 2024 Q2Q % growth | 494.333M 54.82% | 435.88M | 58.453M | 13.41% |
| Q4 2023 Q2Q % growth | 439.718M 31.26% | 451.75M | -12.032M | -2.66% |
| Q3 2023 Q2Q % growth | 750.53M 183.97% | 391.21M | 359.32M | 91.85% |
| Q2 2023 Q2Q % growth | 318.754M 41.79% | 357.52M | -38.766M | -10.84% |
| Q1 2023 Q2Q % growth | 319.29M 49.69% | 318.5M | 790K | 0.25% |
| Q4 2022 Q2Q % growth | 335M 29.59% | 319.4M | 15.6M | 4.88% |
| Q3 2022 Q2Q % growth | 264.3M 40.88% | 297.59M | -33.29M | -11.19% |
| Q2 2022 Q2Q % growth | 224.8M 1.90% | 261M | -36.2M | -13.87% |
| Q1 2022 Q2Q % growth | 213.3M 20.10% | 248.24M | -34.94M | -14.08% |
| Q4 2021 Q2Q % growth | 258.5M 58.01% | 238.3M | 20.2M | 8.48% |
| Q3 2021 Q2Q % growth | 187.6M 49.01% | 223.07M | -35.47M | -15.90% |
| Q2 2021 Q2Q % growth | 220.6M 112.12% | 196.66M | 23.94M | 12.17% |
| Q1 2021 Q2Q % growth | 177.6M 78.49% | 172.11M | 5.49M | 3.19% |
| Q4 2020 Q2Q % growth | 163.6M | 149.74M | 13.86M | 9.26% |
| Q3 2020 Q2Q % growth | 125.9M | 123.17M | 2.73M | 2.22% |
| Q2 2020 Q2Q % growth | 104M | 101.47M | 2.53M | 2.49% |
| Q1 2020 Q2Q % growth | 99.5M | 93.552M | 5.948M | 6.36% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -26.03% | -18.84% | -6.46% | 8.86% |
| Revenue | -4.29% | -2.23% | 1.83% | 6.99% |